Showing results (351-360 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|September 1, 2011
Comparison of the pharmacokinetics of pitavastatin by formulation and ethnic group: an open-label, single-dose, two-way crossover pharmacokinetic study in healthy Caucasian and Japanese menSteve Warrington, Shunji Nagakawa, Neil HounslowClinical Drug Investigation|September 17, 2011
Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational studyGiovanni Guaraldi, Stefano Zona, Gabriella Orlando, et al.Clinical Drug Investigation|October 26, 2011
Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III studyTakefumi Saito, Tomoko HasunumaClinical Drug Investigation|November 1, 2011
Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational studyJing Sun, Yao-Zong Yuan, Gerald HoltmannClinical Drug Investigation|January 6, 2012
A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patientsDavid J Moore, Alastair Greystoke, Fouziah Butt, et al.Clinical Drug Investigation|October 25, 2011
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY StudyShehzad Ali, Noman Paracha, Stuart Cook, et al.Clinical Drug Investigation|October 25, 2011
Efficacy and safety of dutasteride in Chinese adults with symptomatic benign prostatic hyperplasia: a randomized, double-blind, parallel-group, placebo-controlled study with an open-label extensionYanqun Na, Zhangqun Ye, Shanzhong Zhang, et al.Clinical Drug Investigation|April 15, 2014
Younger females are at greater risk of vasodilation-related adverse symptoms caused by dihydropyridine calcium channel blockers: results of a study of 11,918 Japanese patientsAyami Kajiwara, Junji Saruwatari, Ayana Kita, et al.Clinical Drug Investigation|March 29, 2014
Effect of hepatic impairment on the pharmacokinetics of levomilnacipran following a single oral dose of a levomilnacipran extended-release capsule in human participantsLaishun Chen, Ramesh Boinpally, William M Greenberg, et al.Clinical Drug Investigation|March 18, 2014
Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trialWilli Cawello, Christa Mueller-Voessing, Jens-Otto AndreasPageof 233